PAR6 COST-UTILITY ANALYSIS OF RITUXIMAB AS A NEW THERAPEUTIC OPTION FOR RHEUMATOID ARTHRITIS PATIENTS IN CANADA
B Mistry, J McCormick, A Diamantopoulos, A KielhornVolume:
9
Year:
2006
Language:
english
DOI:
10.1016/s1098-3015(10)63265-2
File:
PDF, 71 KB
english, 2006